Phenytoin as seizure prophylaxis in hematopoietic stem cell transplantation with busulfan conditioning

BackgroundPhenytoin is widely used as primary seizure prophylaxis in hematopoietic stem cell transplantation in patients undergoing myeloablative conditioning with busulfan. Because of the negative side effects of phenytoin, we abandoned phenytoin use in these patients. To assess the effect of this...

Full description

Bibliographic Details

Published in:	Frontiers in Neurology
Main Authors:	R. S. Germeraad, A. M. P. Demandt, R. P. W. Rouhl
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-08-01
Subjects:	busulfan phenytoin (PHT) seizure acute symptomatic seizure seizure prophylaxis
Online Access:	https://www.frontiersin.org/articles/10.3389/fneur.2022.928550/full